The Evolution of AffloVest
AffloVest is comfortable, effective, and connected—with over a decade of advancing and improving airway clearance therapy.
The introduction of AffloVest® in 2013 revolutionized the high frequency chest wall oscillation (HFCWO) therapy market by bringing a proven treatment to patients that allowed for mobility during use. Consistently listening to patient and clinician feedback has enabled Tactile Medical to continually improve AffloVest over time and deliver a superior product that patients prefer to use and clinicians want to prescribe.
NEXT Generation AffloVest
Patient-preferred therapy, now enhanced.1
Lighter Weight
With a shorter vest profile and smaller battery, the next generation of AffloVest is 4.3-7.8 lbs. – up to 15% lighter than the previous AffloVest.
Better Adjustability
AffloVest features new shoulder and side straps with large buckles to provide a wider range of adjustability and ease of use that promotes treatment adherence.
Enhanced Controller Navigation
The newly designed controller features a slim profile, convenient buttons, and on-screen icons to help patients navigate therapy options.
Bluetooth® and Wi-Fi connectivity
App connectivity helps patients stay on track with their therapy and feel more confident discussing their therapy with their care team.
1. Wetherby M, Dunn N, Mullenix V, et al. A Patient Preference Study of High-Frequency Chest Wall Oscillation Devices. RT Magazine. May/June 2023. Conducted using 5th generation AffloVest.